Incannex's IHL-42X Lowered AHI, ODI in Obstructive Sleep Apnea Phase 2 Trial
The clinical trial assessed three doses of IHL-42X at reducing the AHI in patients with OSA, as well as collected safety data.
Source: sleepreviewmag.com
Metrics Captured News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Metrics Captured. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Metrics Captured Today - Breaking & Trending Today